ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
-16.1%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$1.67B
AUM Growth
+$1.67B
(-23%)
Cap. Flow
-$107M
Cap. Flow
% of AUM
-6.4%
Top 10 Holdings %
Top 10 Hldgs %
75.78%
Holding
50
New
4
Increased
12
Reduced
12
Closed
14
Top Buys
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$45.5M |
| 2 |
Sarepta Therapeutics
SRPT
|
$36.2M |
| 3 |
Allogene Therapeutics
ALLO
|
$27.8M |
| 4 |
AMRN
Amarin Corp
AMRN
|
$20.8M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
$18.9M |
Top Sells
| 1 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$94.2M |
| 2 |
Puma Biotechnology
PBYI
|
$52.8M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$33.7M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$26.8M |
| 5 |
Catalyst Pharmaceutical
CPRX
|
$17M |
Sector Composition
| 1 | Healthcare | 84.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $253M | 15.11% | 17,714,461 | – | – |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $204M | 12.17% | 4,798,101 | – | – |
|
|
3
Sarepta Therapeutics
SRPT
$1.78B
| $139M | 8.32% | 1,275,000 +331,500 | +35% | +$36.2M |
|
4
Ascendis Pharma
ASND
$11.8B
| $124M | 7.42% | 1,980,000 +16,664 | +0.8% | +$1.04M |
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $116M | 6.92% | 1,360,000 -8,103 | -0.6% | -$690K |
|
6
Amicus Therapeutics
FOLD
$2.34B
| $97M | 5.8% | 10,125,000 +791,868 | +8% | +$7.59M |
|
7
Iovance Biotherapeutics
IOVA
$807M
| $90.8M | 5.43% | 10,261,039 +1,598,319 | +18% | +$14.1M |
|
|
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $85M | 5.08% | 4,350,000 -110,426 | -2% | -$2.16M |
|
9
argenx
ARGX
$43.6B
| $82.6M | 4.94% | 860,000 +104,585 | +14% | +$10M |
|
|
AMRN
10
Amarin Corp
AMRN
$311M
| $75.9M | 4.54% | 5,575,000 +1,530,000 | +38% | +$20.8M |
|
|
ZGNX
11
DELISTED
Zogenix, Inc.
ZGNX
| $72M | 4.3% | 1,975,000 +517,087 | +35% | +$18.9M |
|
|
LOXO
12
DELISTED
Loxo Oncology, Inc
LOXO
| $45.5M | 2.72% | +325,000 | New | +$45.5M |
|
|
TCDA
13
DELISTED
Tricida, Inc. Common Stock
TCDA
| $41.3M | 2.47% | 1,750,000 -21,500 | -1% | -$507K |
|
|
14
Allogene Therapeutics
ALLO
$251M
| $27.8M | 1.66% | +1,128,584 | New | +$27.8M |
|
|
15
Madrigal Pharmaceuticals
MDGL
$9.76B
| $25.4M | 1.52% | 225,000 -238,000 | -51% | -$26.8M |
|
16
Assembly Biosciences
ASMB
$190M
| $22.6M | 1.35% | 1,000,000 -48,427 | -5% | -$1.1M |
|
17
TG Therapeutics
TGTX
$4.65B
| $19.5M | 1.16% | 4,750,000 +549,969 | +13% | +$2.25M |
|
18
Indaptus Therapeutics
INDP
$7.19M
| $18.9M | 1.13% | 2,500,000 -70,705 | -3% | -$533K |
|
|
BDSI
19
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $17.5M | 1.05% | 4,725,000 -712,779 | -13% | -$2.64M |
|
20
Pacira BioSciences
PCRX
$1.2B
| $17.2M | 1.03% | 400,000 -13,196 | -3% | -$568K |
|
21
Xenon Pharmaceuticals
XENE
$2.98B
| $15.1M | 0.91% | 2,400,000 +32,782 | +1% | +$207K |
|
|
GBT
22
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $14.4M | 0.86% | 350,000 +62,500 | +22% | +$2.57M |
|
23
PTC Therapeutics
PTCT
$3.92B
| $13M | 0.78% | 380,000 -304,000 | -44% | -$10.4M |
|
24
Establishment Labs
ESTA
$1.2B
| $13M | 0.78% | 475,000 | – | – |
|
|
TLGT
25
DELISTED
Teligent, Inc
TLGT
| $7.26M | 0.43% | 5,300,000 +569 | +0% | +$780 |
|